[go: up one dir, main page]

FR2699078B1 - Application of lamotrigine in the treatment of neurological lesions linked to trauma. - Google Patents

Application of lamotrigine in the treatment of neurological lesions linked to trauma.

Info

Publication number
FR2699078B1
FR2699078B1 FR9305122A FR9305122A FR2699078B1 FR 2699078 B1 FR2699078 B1 FR 2699078B1 FR 9305122 A FR9305122 A FR 9305122A FR 9305122 A FR9305122 A FR 9305122A FR 2699078 B1 FR2699078 B1 FR 2699078B1
Authority
FR
France
Prior art keywords
lamotrigine
trauma
treatment
application
neurological lesions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9305122A
Other languages
French (fr)
Other versions
FR2699078A1 (en
Inventor
Adam Doble
Erik Louvel
Jeremy Pratt
Jean-Marie Stutzmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9215148A external-priority patent/FR2699077B1/en
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9305122A priority Critical patent/FR2699078B1/en
Publication of FR2699078A1 publication Critical patent/FR2699078A1/en
Application granted granted Critical
Publication of FR2699078B1 publication Critical patent/FR2699078B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9305122A 1992-12-16 1993-04-30 Application of lamotrigine in the treatment of neurological lesions linked to trauma. Expired - Fee Related FR2699078B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9305122A FR2699078B1 (en) 1992-12-16 1993-04-30 Application of lamotrigine in the treatment of neurological lesions linked to trauma.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9215148A FR2699077B1 (en) 1992-12-16 1992-12-16 Application of anticonvulsants in the treatment of neurological lesions linked to trauma.
FR9305122A FR2699078B1 (en) 1992-12-16 1993-04-30 Application of lamotrigine in the treatment of neurological lesions linked to trauma.

Publications (2)

Publication Number Publication Date
FR2699078A1 FR2699078A1 (en) 1994-06-17
FR2699078B1 true FR2699078B1 (en) 1995-01-13

Family

ID=26229958

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9305122A Expired - Fee Related FR2699078B1 (en) 1992-12-16 1993-04-30 Application of lamotrigine in the treatment of neurological lesions linked to trauma.

Country Status (1)

Country Link
FR (1) FR2699078B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt

Also Published As

Publication number Publication date
FR2699078A1 (en) 1994-06-17

Similar Documents

Publication Publication Date Title
EP0792371A4 (en) COMBINED ACNE TREATMENT PROCESS
OA08617A (en) Neutral metalloendopeptidase inhibitors in the treatment of hypertention.
FI933946A7 (en) Compounds useful as hypoglycemic agents and in the treatment of Alzheimer's disease
CA2130275A1 (en) Use of Substituted Adenine Derivatives for Treating Multiple Sclerosis
IT9083334A0 (en) PROCEDURE FOR THE EXTRACTION AND PURIFICATION OF HUMAN GENOMIC DNA
DE69630479D1 (en) Medicines for the treatment of inflammatory heart disease
EP0730453A4 (en) METHODS OF TREATING CARDIAC ARRHYTHMIA
FI944336A0 (en) Cooling cleanser according to the skin's pH value and process for its preparation
EP0754042A4 (en) TREATMENT OF ATHEROSCLEROSIS
EP1141338A4 (en) RECOMBINANT HERPES SIMPLEX VIRUS USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES
FR2695714B1 (en) Installation of cryogenic treatment, in particular of air distillation.
GB9323044D0 (en) In or relating to the treatment of effluents
EP0559791A4 (en) Treatment of topical infections
EP0832204A4 (en) TREATMENT OF INSULIN RESISTANCE
FR2694384B1 (en) Surface treatment of refractories.
FR2690152B1 (en) PROCESS FOR THE PREPARATION AND TREATMENT OF PROPELLANTS.
ITMI931181A1 (en) PROCEDURE FOR ADDITIONAL SALCICCE TREATMENT
FR2684552B1 (en) USE OF D-FENFLURAMINE AND FENFLURAMINE DERIVATIVES IN THE TREATMENT OF HYPERTENSION IN INSULIN RESISTANT SUBJECTS.
FR2558372B1 (en) DRUG COMPOSITION FOR THE TREATMENT OF ACNE
AU7670687A (en) Improvements in or relating to the treatment of occlusive vascular diseases
EP0840605A4 (en) COMPOUNDS USEFUL IN THE TREATMENT OF NEUROFIBROMATOSIS
FR2699078B1 (en) Application of lamotrigine in the treatment of neurological lesions linked to trauma.
GB9216506D0 (en) Improvements in or relating to the treatment of sickle cell disease
GB9111089D0 (en) Improvements in or relating to the treatment of waste
FR2699079B1 (en) Application of anticonvulsants in the treatment of neurological lesions linked to trauma.

Legal Events

Date Code Title Description
ST Notification of lapse